The future of management of benign prostatic hyperplasia

Much has changed over the past few decades in the management of benign prostatic enlargement. The most exciting aspect however, is in the future-there undoubtedly will arise medical and surgical options which boast vastly improved efficacy and safety compared with current treatments. From humble beginnings of blind incision, much has changed and will continue to do so-medical options including more specific subtypes of alpha blockers, and potential newer hormonal agents are around the corner. A variety of pro-apoptotic agents are also being investigated. Lasers, hydro-dissectors, steam ablation and high intensity ultrasound are just a few of the newer technologies emerging onto the market. Whilst various mechanical stents have been developed, many more will arise. Robotics and excitingly, nano-robotics, provide another frontier awaiting exploration. Regardless of your vantage point, new treatments will arise and we are tasked with the responsibility of applying them appropriately and safely, to facilitate the best improvement for our patients.